Lilly Symbyax Combo Clears FDA; Price, Dose Will Help Distinguish Brand
Executive Summary
Lilly's launch plans for the bipolar depression therapy Symbyax combine a value pricing model with a unique dosing combination
You may also be interested in...
Zyprexa Sales Will Decline In Second Half; Symbyax Starts Slow
Lilly is focusing on increasing the trial rate for Symbyax among primary care physicians and psychiatrists to help build sales of the bipolar depression combination product
Zyprexa Sales Will Decline In Second Half; Symbyax Starts Slow
Lilly is focusing on increasing the trial rate for Symbyax among primary care physicians and psychiatrists to help build sales of the bipolar depression combination product
Lilly’s Symbyax Requires Prior Authorization Under Massachusetts Medicaid
Massachusetts Medicaid's MassHealth program is requiring prior authorization for Lilly's antipsychotic/ antidepressant combination agent, Symbyax